Skip to Main Content

Paper Details

CXCL12 promoter methylation and PD-L1 expression as prognostic biomarkers in prostate cancer patients.
Oncotarget
31
2016
Author NameAffiliation
Verena SailerWeill Cornell Medicine of Cornell University
Verena SailerWeill Cornell Medicine of Cornell University, Englander Institute for Precision Medicine
  • 1 - 2

Datasets

Release 1.2